학술논문

Re-sensitization to pembrolizumab following PSMA-CD3 T-cell redirection therapy with JNJ-081 in a patient with mismatch repair-deficient metastatic castration-resistant prostate cancer: a case report
Document Type
Journal
Source
JOURNAL FOR IMMUNOTHERAPY OF CANCER; MAY 2023, 11 5, pe006794 4p.
Subject
Language
English
ISSN
20511426